MarketPulse

pharmaceutical portfolio

2 articles
The Motley FoolThe Motley Fool··Jonathan Ponciano

Ligand CFO Cashes In on 80% Rally; Strong Fundamentals Support Gain

Ligand Pharmaceuticals CFO Octavio Espinoza sold $688K in stock under a prearranged plan. The sale reflects portfolio diversification, not concerns, as the biotech firm posts strong 2025 results.
LGNDbiotechearnings growth
BenzingaBenzinga··Globe Newswire

CDT Equity Bets Big on AI and Pharma with $115M Sarborg Stake

CDT Equity acquires 20% stake in Sarborg AI for $115M while advancing AstraZeneca-licensed pharmaceuticals and exploring capital markets options.
AZNCDTCDTTWagentic AIshareholder value